D
NeuroPace, Inc. NPCE
$8.42 -$0.14-1.64% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -31.29% -25.50% 3.71% 27.44% 15.81%
Total Depreciation and Amortization 3.25% 2.44% 0.00% 1.58% 4.96%
Total Amortization of Deferred Charges 12.24% 0.00% 4.26% -12.96% -30.77%
Total Other Non-Cash Items 32.79% 0.37% 10.22% -22.66% -2.09%
Change in Net Operating Assets 147.88% -45.55% -647.99% 255.68% 86.70%
Cash from Operations 72.12% -55.97% -178.25% 55.79% 48.19%
Capital Expenditure -354.05% 5.13% 61.00% -58.73% 39.42%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- 33.33% -54.55% 32.00%
Cash from Investing -354.05% -101.89% 40.07% -56.75% 35.10%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -99.71% 7,440.64% -68.31% 410.50% -19.42%
Repurchase of Common Stock 99.65% -54,002.17% -35.29% 5.56% 88.91%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -109.04% 2,389.15% -70.74% 469.35% 606.94%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -130.63% 783.55% -177.23% 1,771.43% 96.96%